Concurrent chemoradiotherapy in cervical cancer (A new paradigm in cervical cancer treatment)

Yonsei Medical Journal

Volumn 43, Issue 6, 2002, Pages 749-753

  Ryu, Hee Sug ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Cervical cancer; Concurrent chemoradiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; FLUOROURACIL DERIVATIVE; GEMCITABINE; HYDROXYUREA; MISONODAZOLE; MITOMYCIN C; NITROIMIDAZOLE; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

BONE MARROW SUPPRESSION; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; DRUG MECHANISM; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; LYMPH NODE DISSECTION; NEPHROTOXICITY; RADICAL HYSTERECTOMY; REVIEW; UTERINE CERVIX CANCER;

EID: 0036949054     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2002.43.6.749     Document Type: Review

References (37)

1. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs III CL, et al. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61.
2. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevers RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.
3. Peters III WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13.
4. Rose PG, Bundy BN, Watkins J, Thigpen T, Deppe G, Maiman MA, et al. Concurrent cisplatin based chemotherapy and radiotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
5. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EB, Fowler WC, et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A gynecologic oncology group and southwest oncology group study. J Clin Oncol 1999; 17:1339-48.
6. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
7. Morley GW, Seski JC. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 1976;126:785-98.
8. Volterrani F, Feltre L, Sigurta D, Di Giuseppe M, Luciani L. Radiotherapy versus surgery in the treatment of cervix stage Ib cancer. Int J Radiat Oncol Biol Phys 1983;9:1781-4.
9. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994;29:9-16.
10. Eifel PJ. Chemoradiation for carcinoma of the cervix: Advances and opportunities. Radiat Res 2000;154:229-36.
11. Alberts DS, Garcia D, Mason-Liddil N. Cisplatin in advanced cancer of the cervix: An update. Semin Oncol 1991;18:11-24.
12. Friedlander ML, Kaye SB, Sullivan A, Atkinson K, Elliott P, Coppleson M, et al. Cervical carcinoma: a drug-responsive tumor-experience with combined cisplatin, vinblastine, and bleomycin therapy. Gynecol Oncol 1983;16:275-81.
13. Kim DS, Moon H, Hwang YY, Cho SH. Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor. Gynecol Oncol 1988;29:321-32.
14. Benedetti Panici P, Scambia G, Greggi S, Di Roberto P, Baiocchi G, Mancuso S. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: A pilot study. Obstet Gynecol 1988;74:344-8.
15. Sardi J, Sananes C, Giaroli A, Maya G, di Paola G. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 1990;38:486-93.
16. Dottino PR, Plaxe SC, Beddoe AM. Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol 1991;40:7-11.
17. Chang TC, Lai CH, Chou PC, Tseng CJ, Chang TC, Hsueh S. Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery m early-stage bulky cervical carcinoma. Cancer Chemother Pharmacol 1992;30:281-5.
18. Zanetta G, Landoni F, Colombo A, Pellegrino A, Maneo A, Leventis C. Three-year results after neoadjuvant chemotherapy, radical surgery, and radiotherapy in locally-advanced cervical carcinoma. Obstet Gynecol 1993;82:447-50.
19. Thomas G, Dembo A, Fyles A, Gadalla T, Beale F, Bean H, et al. Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol 1990:38;446-51.
20. Leborgne F, Leborgne JH, Doldan R, Zubizarreta E, Ortega B, Maisonneuve J, et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: A pilot study and phase III randomized trial. Int J Radiat Oncol Biol Phys 1997:37;343-50.
21. Steel GG, Peckham MJ. Expoliatable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 1979;5:85-91.
22. Piver MS, Howes AE, Suit HD, Marshall N. Effect of hydroxyurea on the radiation response of CH3 mouse mammary tumors. Cancer 1972;29:407-12.
23. Sinclair W. The combined effect of hydroxyurea and x-rays on Chinese hamster cells in vitro. Cancer Res 1968;28:198-201.
24. Carde P, Laval F. Effect of cis-dichlorodiamine platinum II and X-rays on mammalian cell survival. Int J Radiat Oncol Biol Phys 1981;7:929-33.
25. Kallman RF, Rapacchietta D, Zaghloul MS. Schedule-dependent therapeutic gain from the combination of fractionator irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems. Int J Radiat Oncol Biol Phys 1991;20: 227-32.
26. Grem JL, Mechanisms of action and modulation of fluorouracil. Semin Radiat Oncol 1997,7:249-59.
27. Piver MS, Barlow JJ, Vongtama V, Webester J. Hydroxyurea and radiation therapy in advanced cervical cancer. Am J Obstet Gynecol 1974;120:407-12.
28. Piver MS, Barlow JJ, Vongtama V, Blumenson L. Hydroxyurea: A radiation potentiator in carcinoma of the uterine cervix. Am J Obstet Gynecol 1983;147:803-8.
29. Stehman FB, Bundy BN, Keys HM, Thomas G, d'Ablaing III G, Fowler WC, et al. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix: A preliminary report of a gynecologic oncology group study. Am J Obstet Gynecol 1988;159:87-94.
30. Stehman FB, Bundy BN, Thomas G, Keys HM, d'Ablaing III G, Fowler WC, et al. Hydroxyurea versus misonidazole with radiation in cervical carcinoma; Long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol 1993;11:1523-8.
31. Park YH, Ryu HS, Chang KH, Chun M, Yoon JH, Ryou JM, et al. The value of concurrent chemoradiotherapy in the treatment of loco-regionally advanced cervical cancer. Korean J Obstet Gynecol 2002;45:633-41.
32. Rakovitch E, Fyles AW, Pintilie M, Leung PM. Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1997; 38:979-87.
33. Hogan WM, Littman P, Griner L, Miller MS, Mikuta JJ. Results of radiation therapy given after radical hysterectomy. Cancer 1982;49:1278-85.
34. Pedulla F, Centurioni MG, Foglia G, Ferrari I, Orsatti M, Vitale V, et al. Treatment of FIGO stage Ib cervical carcinoma with nodal involvement. Eur J Gynaecol Oncol 1994;15:59-64.
35. Kim YA, Ryu HS, Chun M, Chang KH, Park YH, Oh KS. Postoperative adjuvant CCRT(concurrent chemoradiotherapy) for selected early stage cervical cancer patients following radical hysterectomy and pelvic lymph node dissection. Korean J Obstet Gynecol 2000; 43:1725-9.
36. Berek J, Hacker N. Practical Gynecologic Oncology. 3rd ed. Philidelphia, PA: Lippincot Williams & Wilkins Co.; 2000. p.367-8.
37. Sardi J, Sananes C, Giaroli A, Bayo J, Gomez Rueda N, Vighi S, et al. Result of a prospective randomized trial with neoadjuvant chemotherapy in stage Ib, bulky, squamous carcinoma of the cervix. Gynecol Oncol 1993;49:156-65.